LIVE CME/CE WEBINAR · TALEM NEXUS
Optimizing Managed Care Decision-Making in Advanced Nonmelanoma Skin Cancer
Integrating evidence, guidelines, and care pathways to support appropriate utilization management and individualized treatment decisions in advanced nonmelanoma skin cancer.
About the program
This live CME/CE program is designed for managed care professionals and focuses on decision-making in advanced nonmelanoma skin cancer. Faculty will review contemporary evidence, treatment guidance, and care pathways relevant to the management of patients with advanced disease.
The discussion will emphasize how clinical evidence can inform utilization management strategies, treatment selection, and individualized care within managed care settings, with attention to the practical decisions faced by medical directors, pharmacists, and other healthcare decision-makers.
The program is part of a broader TALEM Nexus educational initiative focused on improving access, quality, safety, and outcomes through evidence-based managed care education.
Faculty
David M. Miller, MD, PhD
Assistant Professor of Medicine and Dermatology, Harvard Medical School
Hiva Pourarsalan, PharmD
Director of Pharmacy, Mercy Care Advantage; Aetna, a CVS Health Company
Ryan Atkinson, PharmD
Vice President, Payer Contracting, Amber Specialty Pharmacy
Program details
Date
Saturday, September 26, 2026
Time
8:00–9:15 AM Central Time
Format
Live CME/CE webinar
Credit
1.0 CME/CE
Audience
Medical directors, managed care pharmacists, and other decision-makers working in managed care settings
Educational focus
Advanced nonmelanoma skin cancer; evidence integration; guidelines; utilization management; care pathways
This site represents our opinions only. See our full Disclaimer and Terms of Use Agreement.